The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Intratumor heterogeneity as an opportunity for drug sensitivity prediction and biomarker discovery.
Qiang Gao
No relevant relationships to disclose
William Niu
No relevant relationships to disclose
Andrew Tse
No relevant relationships to disclose
Jeffrey Lin
No relevant relationships to disclose
Zhou Jian
No relevant relationships to disclose
Simon Shung
No relevant relationships to disclose
Fan Jia
No relevant relationships to disclose